Concepedia

Yukinori Minoshima

YM

Statistics

Publications

27

Citations

3.1K

H-Index

20

Active since

2001

Affiliations

Eisai (Japan)(Current)

Eisai (United States)

The University of Tokyo

Tokyo University of Science

Kyoto University

Yukinori Minoshima is an author at Eisai (Japan) specializing in oncology, medicine, and cancer pharmacology.

ORCID

Publications per year

2001–2024

27

Publications

27

Selective Inhibition of EZH2 by EPZ-6438 Leads to Potent Antitumor Activity in <i>EZH2</i> -Mutant Non-Hodgkin Lymphoma

Sarah K. Knutson, Satoshi Kawano, Yukinori Minoshima et al. · Molecular Cancer Therapeutics · 2014 · 522 citations

, , +14

Antitumor Activity of Lenvatinib (E7080): An Angiogenesis Inhibitor That Targets Multiple Receptor Tyrosine Kinases in Preclinical Human Thyroid Cancer Models

Osamu Tohyama, Junji Matsui, Kotaro Kodama et al. · Journal of Thyroid Research · 2014 · 480 citations · Full text

, , +17

Selective degradation of splicing factor CAPERα by anticancer sulfonamides

Taisuke Uehara, Yukinori Minoshima, Koji Sagane et al. · Nature Chemical Biology · 2017 · 379 citations

, , +14

Phosphorylation by Aurora B Converts MgcRacGAP to a RhoGAP during Cytokinesis

Yukinori Minoshima, Toshiyuki Kawashima, Koichi Hirose et al. · Developmental Cell · 2003 · 312 citations · Full text

, , +6

Lenvatinib inhibits angiogenesis and tumor fibroblast growth factor signaling pathways in human hepatocellular carcinoma models

Masahiro Matsuki, Taisuke Hoshi, Yuji Yamamoto et al. · Cancer Medicine · 2018 · 262 citations · Full text

, , +17

1–5 of 27